RE: RE: RE: RE: I do see it.... I read about this stock the first time in washington post, as one of the top ten innovative co.s, but after a bit of research I just do not see any major revenue being generated through even an FDA approval and marketing of dispersin B or D or whatever they call it.... A nice story to hear but far away from business reality... FDA could play the spoiler as this is not hard to see, even to someone like me, right? LOL